All molecules
CRITICAL CN/IN ONLY

Primaquine

Malaria relapse prevention

2qualified API sources for the US and EU combined
US · active DMF holders2
EU · valid CEP holders1
EU CEP holder countriesIN

Every valid EU CEP is held in China or India.

Listed as critical or essential by
  • WHO Model List

Who holds these files? Names, sites and contacts are in the API-FDF database.

See who's in

How we count

01

Companies, not documents

We count companies, not documents. A qualified source is a company that holds an active Type II Drug Master File on FDA's list (third quarter 2026) or a valid Certificate of Suitability in the EDQM database (checked 14 November 2026). Files for intermediates and finished products are left out.

02

Three official lists

The molecules come from three lists: the EU Union list of critical medicines (version 2.1, November 2026), FDA's essential medicines list under Executive Order 13944, and the WHO Model List of Essential Medicines (24th list, 2025). Vaccines, blood products, antibodies, insulins and simple salts are not counted.

03

A file is not a shipment

An active file shows that a company can supply the US or EU market. It does not prove that it ships today. Zero means no open file in either registry: the ingredient may still be made in-house by the brand owner or under another route, such as WHO prequalification.

04

Hidden by default

Brand-only molecules, where few makers are expected while the patent runs, and a few commodity substances sold mostly outside these files are marked and hidden by default.